CMV infection is known to modulate the adaptive anti-viral immune response by impairing the surface expression of a variety of molecules, such as major histocompatability complex (MHC) class I and II, CD80, and CD86 [29], [33]–[35]. The gene discussed is CD86; the disease is cytomegalovirus infection.